STOCK TITAN

ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) will participate in the 34th Annual Piper Sandler Healthcare Conference on November 30, 2022, at 9:30 a.m. Eastern Time. President and CEO Scott Drake and CFO Zach Stassen will engage in a fireside chat. An audio webcast of the event will be accessible on the investor relations section of ViewRay's website, with a replay available for seven days post-event. ViewRay specializes in the MRIdian MRI-Guided Radiation Therapy System, designed to tackle challenges in advanced radiation oncology.

Positive
  • None.
Negative
  • None.

DENVER, Nov. 14, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the 34th Annual Piper Sandler Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 9:30 a.m. Eastern Time on Wednesday, November 30, 2022.

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at https://investors.viewray.com/events-and-webinars. A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

 

Cision View original content:https://www.prnewswire.com/news-releases/viewray-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference-301676622.html

SOURCE ViewRay, Inc.

FAQ

When is ViewRay's presentation at the Piper Sandler Healthcare Conference?

ViewRay's presentation is scheduled for November 30, 2022, at 9:30 a.m. Eastern Time.

Who will represent ViewRay at the conference?

Scott Drake, President and CEO, and Zach Stassen, CFO, will represent ViewRay at the conference.

Where can I listen to ViewRay's presentation?

The presentation can be listened to via an audio webcast available on ViewRay's investor relations website.

How long will the webcast replay of ViewRay's presentation be available?

The replay of the webcast will be available for seven days after the presentation.

What does ViewRay specialize in?

ViewRay specializes in the MRIdian MRI-Guided Radiation Therapy System, addressing unique challenges in advanced radiation oncology.

ViewRay Inc.

NASDAQ:VRAY

VRAY Rankings

VRAY Latest News

VRAY Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Oakwood Village